Call for Clarity in the Reporting of Benefit Associated With Anticancer Therapies

Clinical benefit in oncology trials: Is this a patient-centred or tumour-centred end-point?

(2009) Pavlo Ohorodnyk et al.   EUROPEAN JOURNAL OF CANCER

Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer

(2009) Daniel D. Karp et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma

(2009) Luis H. Camacho et al.   JOURNAL OF CLINICAL ONCOLOGY

Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study

(2009) Gunter von Minckwitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Progress in Cancer Care: The Hope, the Hype, and the Gap Between Reality and Perception

(2008) Leonard B. Saltz   JOURNAL OF CLINICAL ONCOLOGY

Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non–Small-Cell Lung Cancer: Results From Southwest Oncology Group Randomized Trials

(2008) Primo N. Lara et al.   JOURNAL OF CLINICAL ONCOLOGY

Reflections on Medical Oncology: 25 Years of Clinical Trials—Where Have We Come and Where Are We Going?

(2007) Christopher M. Booth et al.   JOURNAL OF CLINICAL ONCOLOGY